Brind.
  1. A company operating on the New York Stock Exchange confirms its adherence to U.S. securities laws.

Park Ha Biological Technology Co., Ltd. is facing a US securities class action while maintaining operational franchise stores in China.

1 report, 1 independent Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Park Ha Biological Technology Co., Ltd. is facing a US securities class action while maintaining operational franchise stores in China.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Levi & Korsinsky, LLP filed a securities class action lawsuit against Park Ha Biological Technology Co., Ltd. in the Southern District of New York.Sub-event
  2. Park Ha Biological Technology Co., Ltd. sells skincare and cosmetic products in China.Sub-event
  3. Company faces US securities class action while operating in China.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped